This inventor holds 19 USPTO granted patents and 14 published patent applications, plus 3 CIPO patents and 9 EPO patents, primarily in Pharmacological Chaperones. Top assignees: Amicus Therapeutics, Inc., Transcriptx, Inc., Amacus Therapeutics, Inc.. Active years: 2010-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Princeton, NJ (US) (2010 - 2014)
- San Diego, CA (US) (2013 - 2023)
Company Filing History:
15 out of 161 
3 out of 3 
1 out of 1 Years Active: 2010-2023
Areas of Expertise:
Title: The Innovative Contributions of Brandon Alan Wustman in Genetic Treatments
Introduction: Brandon Alan Wustman, based in San Diego, CA, is a prominent inventor with a remarkable portfolio of 19 patents. His work primarily focuses on advancing genetic therapies and addressing various medical conditions through innovative methodologies.
Latest Patents: Among his latest contributions, Wustman has developed significant patents related to the treatment of primary ciliary dyskinesia using synthetic messenger RNA. His patents disclose polynucleotides encoding peptides, proteins, enzymes, and functional fragments that can be effectively delivered to organs, particularly the lungs, where they facilitate necessary expression within the organ's cells. These polyribonucleotides show promise in treating diseases associated with cilia maintenance and function, specifically targeting impairments related to axoneme features, such as those caused by DNAI1 or DNAH5 mutations.
Career Highlights: Wustman’s career has been marked by noteworthy tenures at innovative companies such as Amicus Therapeutics, Inc. and Transcriptx, Inc. His experiences at these organizations have allowed him to further develop his research and propel his inventions into practical applications that may benefit countless patients.
Collaborations: Throughout his career, Wustman has collaborated with notable professionals in the field. Among his coworkers are Elfrida Benjamin and Hung V Do, who have supported and contributed to various aspects of his research and invention processes.
Conclusion: Brandon Alan Wustman stands out as a dedicated inventor whose work significantly impacts the realm of genetic treatments. His innovative patents offer hopeful advancements in addressing critical medical conditions, particularly those affecting ciliary function, showcasing his commitment to improving health outcomes through scientific innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile